Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations

PLoS ONE - United States
doi 10.1371/journal.pone.0115256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The Ca2+-Activated Cation Channel TRPM4 Is a Negative Regulator of Angiotensin II-induced Cardiac Hypertrophy

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2015English

PM2.5 Induced Cardiac Hypertrophy via CREB/GSK3b/SOS1 Pathway and Metabolomics Alterations

Oncotarget
Oncology
2018English

Nuclear Factor-κB Activation Leads to Down-Regulation of Fatty Acid Oxidation During Cardiac Hypertrophy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Neonatal Dexamethasone Treatment Leads to Alterations in Cell Signaling Cascades Controlling Hepatic and Cardiac Function in Adulthood

Neurotoxicology and Teratology
ToxicologyDevelopmental NeuroscienceCellularMolecular Neuroscience
2010English

cGMP and Cardiac Hypertrophy

BMC pharmacology & toxicology
MedicinePharmacology
2015English

TRPM4 Mutation in Patients With Ventricular Noncompaction and Cardiac Conduction Disease

Circulation. Genomic and precision medicine
GeneticsCardiovascular MedicineCardiology
2018English

The TRPM4 Channel Inhibitor 9-Phenanthrol Modulates Cardiac Sodium Channel

British Journal of Pharmacology
Pharmacology
2018English

Retraction: Alcohol Consumption and Hormonal Alterations Related to Muscle Hypertrophy: A Review

Nutrition and Metabolism
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2014English

Impairment in Acetylcholine Release by Cardiomyocytes Leads to Enhanced Pathological Hypertrophy

Biophysical Journal
Biophysics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy